国家治疗指南在患有2型糖尿病的老年人中实现不佳 - 呼吁采取行动!
Maika Kummel1, Emma Luther-Tontasse2, Jaana Koskenniemi3
1Turku University of Applied Sciences/Health and Well-being, Turku, Finland; Faculty of Medicine/Clinical Medicine, Department of General Practice, University of Turku and The wellbeing services county of Southwest Finland, Turku, Finland.
Primary care diabetes
|February 11, 2024
概括
在75岁的芬兰人中观察到不控制的2型糖尿病 (T2D) 的高率. 诸如药物使用,肥胖,酒精,健康状况不佳和财务状况等因素影响了治疗目标的实现.
科学领域:
- 老年学和内分泌学.
- 公共卫生研究 公共卫生研究
背景情况:
- 在老年人中,2型糖尿病 (T2D) 的管理带来了独特的挑战.
- 国家治疗指南旨在优化T2D患者的治疗结果.
- 评估老年人群遵守和实现这些准则至关重要.
研究的目的:
- 评估导致75岁芬兰T2D患者未能达到治疗目标的风险因素和相关因素.
- 确定与未达到禁食血糖 (FBG),低密度脂蛋白胆固醇 (LDL-C) 和血压 (BP) 目标相关的特定因素.
主要方法:
- 进行了一项横截面研究,涉及来自图尔库高级卫生诊所研究的75岁T2D的247名参与者.
- 收集了FBG,LDL-C和BP水平的数据,与国家治疗指南进行了比较.
- 统计分析确定了与未达到目标水平相关的因素.
主要成果:
- 发现了高水平的非实现率:FBG为47%,BP为85%,LDL-C为47%.
- 不使用T2D药物和中心肥胖与未达到FBG目标有关.
- 酒精使用和自我评价健康状况不佳影响了BP目标的实现,而财务状况不佳和不使用降脂药物影响了LDL-C目标.
结论:
- 较老的T2D患者表现出高率的未达到国家治疗目标.
- 诸如药物坚持,肥胖,酒精消费,整体健康状况和社会经济因素等因素显著影响治疗结果.
- 个性化的目标设定和积极的管理策略对于改善老年人T2D护理至关重要.
相关概念视频
Diabetes: Management and Pharmacotherapy
285
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
285
Diabetes: Symptoms, Diagnosis, and Complications
544
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
544
Diabetes Mellitus: Overview and Type I Subtype
2.6K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.6K
Diabetes Mellitus: Type 2 and Gestational
2.4K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.4K
Carbohydrate Metabolism
11.1K
Carbohydrates are polymers composed of molecules containing atoms of carbon, hydrogen and oxygen. One gram of carbohydrate can provide four kilo-calories of energy, which makes it the most efficient instant energy source.
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
11.1K
Oral Hypoglycemic Agents: Biguanides and Glitazones
201
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
201


